Gold Nanoparticles in Biomedical Applications: Synthesis, Functionalization, and Recent Advances

Gold nanoparticles (AuNPs) are metallic nanoparticles with strong biomedical potential and have FDA approval. Their nanoscale size, optical tunability, and biocompatibility allow them to be used for tumor-targeted delivery, photothermal therapy, imaging contrast, radiosensitization, gene transfection, biosensing, personalized medicine and AI-supported healthcare solutions. These properties made AuNPs a game-changing tool in nanomedicine.

Google Scholar, PubMed, Scopus and ScienceDirect were used to search the literature with keywords related to gold nanoparticles, synthesis, functionalization and advanced applications in biomedicine. The search mainly focused on studies published between 2018-2025, and older landmark papers were only included when needed to describe classical synthesis.

Standard AuNP synthesis and functionalization approaches were compared with advanced methods such as green synthesis, microfluidic synthesis, polymer functionalization and AI-supported synthesis optimization. AuNPs moved from traditional drug administration and basic diagnostics into multiplex imaging, targeted therapy, hybrid theranostics, spectral CT imaging, gene delivery and CRISPR-related applications.

This review demonstrates the evolution of AuNPs in biomedicine from traditional nanoparticles to sophisticated multifunctional nanosystems. To the best of our knowledge, this is the first assessment that explicitly contrasts sophisticated AuNP techniques with conventional procedures in biomedical applications.